Alpine Global Management’s AstraZeneca AZN Stock Holding History

Alpine Global Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-453	Closed	-$29K	–	156
2015 Q2	$29K	Buy	+453	New	+$31K	﹤0.01%	879

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Alpine Global Management's AZN Position: Q3 2015 in Review

Alpine Global Management sold out of AstraZeneca (AZN) in Q3 2015, closing a stake of 453 shares — an estimated $29K sold.

Alpine Global Management first reported a position in AZN in Q2 2015 and held it in 1 quarter. The position peaked at $29K in Q2 2015. 370 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

Alpine Global Management reported no remaining AstraZeneca position as of Q3 2015 after selling out during the quarter.
Alpine Global Management sold 453 AstraZeneca shares in Q3 2015, an estimated $29K.
Alpine Global Management first reported a position in AstraZeneca in Q2 2015 and held it in 1 quarter.
Alpine Global Management's AstraZeneca position peaked at $29K in Q2 2015.
370 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on Alpine Global Management's 13F filing for Q3 2015, filed 10 Nov 2015.